Karen B. Avraham

14.5k total citations · 1 hit paper
171 papers, 8.7k citations indexed

About

Karen B. Avraham is a scholar working on Sensory Systems, Molecular Biology and Neurology. According to data from OpenAlex, Karen B. Avraham has authored 171 papers receiving a total of 8.7k indexed citations (citations by other indexed papers that have themselves been cited), including 110 papers in Sensory Systems, 101 papers in Molecular Biology and 30 papers in Neurology. Recurrent topics in Karen B. Avraham's work include Hearing, Cochlea, Tinnitus, Genetics (109 papers), Vestibular and auditory disorders (29 papers) and Cancer-related molecular mechanisms research (22 papers). Karen B. Avraham is often cited by papers focused on Hearing, Cochlea, Tinnitus, Genetics (109 papers), Vestibular and auditory disorders (29 papers) and Cancer-related molecular mechanisms research (22 papers). Karen B. Avraham collaborates with scholars based in Israel, United States and Palestinian Territory. Karen B. Avraham's co-authors include Amiel A. Dror, Yoram Groner, Tama Sobe, Moien Kanaan, Mary‐Claire King, Hashem Shahin, Thomas B. Friedman, Karen P. Steel, Tom Walsh and Lilach M. Friedman and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Karen B. Avraham

166 papers receiving 8.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeted Disruption of the Mouse Caspase 8 Gene Ablates Cell Death Induction by the TNF Receptors, Fas/Apo1, and DR3 and Is Lethal Prenatally

1998 999 citations Eugene Varfolomeev, Marcus Schuchmann et al. Immunity profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karen B. Avraham Israel	48	5.2k	4.0k	1.3k	979	889	171	8.7k
Andrew Forge United Kingdom	46	3.5k 0.7×	5.8k 1.5×	1.8k 1.4×	582 0.6×	1.7k 1.9×	131	8.2k
Hannie Kremer Netherlands	44	5.1k 1.0×	2.3k 0.6×	1.1k 0.8×	674 0.7×	494 0.6×	188	8.0k
Bradley A. Schulte United States	53	4.1k 0.8×	4.0k 1.0×	1.7k 1.3×	367 0.4×	1.5k 1.7×	199	8.7k
Guy Van Camp Belgium	65	6.3k 1.2×	7.3k 1.9×	3.2k 2.3×	841 0.9×	2.4k 2.7×	385	14.3k
Thomas R. Van De Water United States	50	1.8k 0.4×	4.5k 1.1×	1.5k 1.1×	419 0.4×	1.7k 1.9×	161	6.7k
Qing Yin Zheng United States	35	1.9k 0.4×	2.4k 0.6×	887 0.7×	238 0.2×	811 0.9×	119	5.0k
Shin‐ichi Usami Japan	47	3.3k 0.6×	5.3k 1.3×	2.5k 1.9×	260 0.3×	1.8k 2.0×	337	8.5k
Lin Gan United States	52	6.7k 1.3×	907 0.2×	532 0.4×	1.4k 1.5×	383 0.4×	187	9.6k
Hirotaka James Okano Japan	44	3.8k 0.7×	734 0.2×	541 0.4×	627 0.6×	462 0.5×	156	7.5k
Hossein Najmabadi Iran	41	3.5k 0.7×	1.0k 0.3×	500 0.4×	493 0.5×	252 0.3×	292	6.5k

Countries citing papers authored by Karen B. Avraham

Since Specialization

Citations

This map shows the geographic impact of Karen B. Avraham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen B. Avraham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen B. Avraham more than expected).

Fields of papers citing papers by Karen B. Avraham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen B. Avraham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen B. Avraham. The network helps show where Karen B. Avraham may publish in the future.

Co-authorship network of co-authors of Karen B. Avraham

This figure shows the co-authorship network connecting the top 25 collaborators of Karen B. Avraham. A scholar is included among the top collaborators of Karen B. Avraham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen B. Avraham. Karen B. Avraham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brownstein, Zippora, Yoel Hirsch, Hagar Mor‐Shaked, et al.. (2025). A multicenter study reveals a novel pathogenic splice-site founder variant in OTOF. Human Genomics. 19(1). 112–112.

Taiber, Shahar, et al.. (2025). AAV gene therapy rescues hearing and balance in a model of CLIC5 deafness. EMBO Molecular Medicine. 17(9). 2233–2257. 1 indexed citations

Wagner, Elizabeth L., Jun‐Sub Im, Sihan Li, et al.. (2023). Repair of noise-induced damage to stereocilia F-actin cores is facilitated by XIRP2 and its novel mechanosensor domain. eLife. 12. 6 indexed citations

Halpérin, Daniel, Yuval Yogev, Ohad Wormser, et al.. (2023). SMARCA4 mutation causes human otosclerosis and a similar phenotype in mice. Journal of Medical Genetics. 61(2). 117–124.

Çetin, Hakan, David T. Liu, Franco Laccone, et al.. (2022). A homozygous AP3D1 missense variant in patients with sensorineural hearing loss as the leading manifestation. Human Genetics. 142(8). 1077–1089. 3 indexed citations

Avraham, Karen B., et al.. (2022). The long and short: Non-coding RNAs in the mammalian inner ear. Hearing Research. 428. 108666–108666. 11 indexed citations

Avraham, Karen B., et al.. (2021). The noncoding genome and hearing loss. Human Genetics. 141(3-4). 323–333. 14 indexed citations

Rabinowitz, Tom, Zippora Brownstein, Karen B. Avraham, et al.. (2021). PNPT1 , MYO15A , PTPRQ , and SLC12A2 ‐associated genetic and phenotypic heterogeneity among hearing impaired assortative mating families in Southern India. Annals of Human Genetics. 86(1). 1–13. 8 indexed citations

Cohen‐Barak, Eran, et al.. (2020). Homozygote loss-of-function variants in the human COCH gene underlie hearing loss. European Journal of Human Genetics. 29(2). 338–342. 10 indexed citations

10.

Taiber, Shahar, et al.. (2020). Neonatal AAV gene therapy rescues hearing in a mouse model of SYNE4 deafness. EMBO Molecular Medicine. 13(2). e13259–e13259. 50 indexed citations

11.

Dror, Amiel A., Shahar Taiber, Eyal Sela, Ophir Handzel, & Karen B. Avraham. (2020). A mouse model for benign paroxysmal positional vertigo with genetic predisposition for displaced otoconia. Genes Brain & Behavior. 19(5). e12635–e12635. 10 indexed citations

12.

Taiber, Shahar & Karen B. Avraham. (2019). Genetic Therapies for Hearing Loss: Accomplishments and Remaining Challenges. Neuroscience Letters. 713. 134527–134527. 15 indexed citations

13.

Brownstein, Zippora, Süleyman Gülsüner, Morad Khayat, et al.. (2018). Genetics of hearing loss in the Arab population of Northern Israel. European Journal of Human Genetics. 26(12). 1840–1847. 19 indexed citations

14.

Brownstein, Zippora, et al.. (2014). Apparent phenotypic anticipation in autosomal dominant connexin 26 deafness. Journal of Basic and Clinical Physiology and Pharmacology. 25(3). 289–292.

15.

Brownstein, Zippora, et al.. (2013). Advances in genetic diagnostics for hereditary hearing loss. Journal of Basic and Clinical Physiology and Pharmacology. 24(3). 165–170. 10 indexed citations

16.

Behar, Doron M., Bella Davidov, Zippora Brownstein, et al.. (2013). The Many Faces of Sensorineural Hearing Loss: One Founder and Two Novel Mutations Affecting One Family of Mixed Jewish Ancestry. Genetic Testing and Molecular Biomarkers. 18(2). 123–126. 7 indexed citations

17.

Avraham, Karen B. & Moien Kanaan. (2012). Genomic advances for gene discovery in hereditary hearing loss. Journal of Basic and Clinical Physiology and Pharmacology. 23(3). 93–97. 11 indexed citations

18.

Shahin, Hashem, Amal Rayan, Karen B. Avraham, et al.. (2010). Nonsense mutation of the stereociliar membrane protein gene PTPRQ in human hearing loss DFNB84. Journal of Medical Genetics. 47(9). 643–645. 34 indexed citations

19.

Walsh, Tom, Sarah Vreugde, Ronna Hertzano, et al.. (2002). From flies' eyes to our ears: Mutations in a human class III myosin cause progressive nonsyndromic hearing loss DFNB30. Proceedings of the National Academy of Sciences. 99(11). 7518–7523. 170 indexed citations

20.

Varfolomeev, Eugene, Marcus Schuchmann, Victor Luria, et al.. (1998). Targeted Disruption of the Mouse Caspase 8 Gene Ablates Cell Death Induction by the TNF Receptors, Fas/Apo1, and DR3 and Is Lethal Prenatally. Immunity. 9(2). 267–276. 999 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact